Exam Review Notes

Exam Details

  • The final exam will consist of approximately 150 questions.
    • About 95-100 questions will be from past semesters.
    • The remaining 50 questions will cover material from the last 6 topics.
  • The format and style of questions will be similar to previous exams, with no significant changes.

Question Types

  • There might be some repeat questions from previous tests or in-class discussions.
  • Avoid publicizing exam questions to maintain fairness.

Content Focus

  • Focus on nursing considerations and the rationale behind drug administration instead of memorizing dosages.
  • For drugs like insulins, know peak times and durations.
    • Example: Understand when to check blood sugar levels after insulin administration based on peak times.
  • Be familiar with normal ranges for basic components of a Complete Blood Count (CBC), but don't get bogged down in specifics.

Lab Values

  • For lab values like platelets, understand the implied scaling (e.g., a platelet count of 24 means 24,000).
  • Be careful with trailing zeros in lab values.
    • Example: a white blood cell count of 9 is likely 9,000, not 9.

HIV and AIDS

  • Know what a normal CD4 count is.
  • Understand the implications of CD8 counts relative to CD4 counts.
  • A CD4 count below 200 is a diagnostic criterion for AIDS.
    • CD4 < 200
  • In AIDS, the CD4 count is low, and the CD8 count remains relatively stable.
  • Understand the CD4/CD8 ratio.

Scleroderma Case Study

  • Patient Joanne Mitchell presents with painful hands and feet (Raynaud's phenomenon) and acid reflux.
  • Health history includes hysterectomy and is apoptotic.
  • Differential diagnosis: Scleroderma.
  • Scleroderma is a systemic connective tissue disorder characterized by excessive collagen production and thickening of the skin and internal organs.
  • Signs and symptoms include Raynaud's phenomenon, GERD, and calcinosis (calcium buildup in the skin).
  • Raynaud's phenomenon involves sudden obstruction of blood flow in distal extremities.
  • Risk factors include GERD and decreased mobility.
  • Potential causes of scleroderma include environmental and autoimmune factors.
  • Diagnosis is confirmed via skin biopsy, which would show excessive connective tissue.
  • Lab values to consider: ESR, CRP, ANA (if antibodies are present), white blood cells, and possibly thrombocytopenia and low hematocrit (anemia).
  • Treatment goals focus on slowing progression and managing symptoms.

Therapeutic Communication

  • Provide support, manage pain, and maintain dignity.
  • Provide education about the disease process and treatment options.

Scleroderma Treatments

  • Corticosteroids: Manage inflammation; taper dosage to avoid adrenal issues, monitor for hyperglycemia and infection
  • NSAIDs: For inflammation; monitor for GI issues (e.g., black tarry stools).
  • Immunosuppressants: Slow down the immune system's attack on the body.

Potential Complications of Scleroderma

  • Right-sided heart failure due to stiffening of the lungs $ \text{stiff lungs lead to back up to the } \text{Rt side of the heart}$ .
  • Dysrhythmias due to hardening of the cardiac wall.
  • GI problems and urinary complications due to tissue stiffening.

Rheumatoid Arthritis (RA)

  • Focus on early and late signs and symptoms.
  • Early signs and symptoms include:
    • Low-grade fever (below 100°F or < 37.8^{\circ}C ).
  • Late signs and symptoms include:
    • Muscle atrophy and weakness.
    • Nodules.
    • Sjogren's syndrome (reduced saliva production, causing increased aspiration risk).
  • Diagnosis involves labs, radiology (X-ray, CT, MRI, bone scan), and arthrocentesis.
  • Treatment is similar to Systemic Lupus Erythematosus (SLE).
  • Focus on physical therapy and weight management.
  • Low-impact activities like swimming are preferred.
  • Synovial membrane inflammation is a key characteristic.

Corticosteroid Complications

  • Complications include:
    • Hyperglycemia
    • Muscle cramps
    • Hypernatremia
    • Osteoporosis

HIV Case Study

  • Patient Clarence tests positive for HIV.
  • The seroconversion window (3 weeks) may lead to false-negative results early after infection; retesting is necessary.
  • Potential transmission circumstances include unsafe sex.
  • HIV-1 is the primary type discussed; HIV-2 is mainly in West Africa.
  • Signs and symptoms within the first 2-4 weeks may include fever and chills.

HIV Diagnosis

  • Diagnostic tests include monitoring CD4 and CD8 cell counts and viral load testing.
  • Normal CD4/CD8 ratio is greater than 1; a ratio less than 1 indicates disease.
  • Viral load indicates the amount of virus in the body; a low viral load means less virus.
  • An undetectable viral load is less than 50 copies/mL.

HIV Stages

  • Acute phase: Flu-like symptoms occur days to weeks after contracting HIV.
  • Chronic (latent/asymptomatic) phase: Lasts for several years.
  • AIDS: Occurs when CD4 cell counts fall below 200, making the person vulnerable to opportunistic infections.

HIV Treatment

  • Protease inhibitors: Bind to protease, blocking HIV replication.
  • Non-nucleoside reverse transcriptase inhibitors: Directly bind to and inhibit HIV reverse transcriptase.
  • Monoclonal antibodies (MABs): Interfere with conformational changes required for virus-free cell fusion.
  • Strict adherence to antiviral medication is crucial; missing even one dose can increase viral replication.

HIV Prevention

  • Pre-exposure prophylaxis (PrEP): Used by uninfected individuals to protect against potential exposure.
  • Post-exposure prophylaxis (PEP): Used after potential exposure; requires a doctor's prescription; must be started with 72hours.

HIV & AIDS Nursing Implications

  • Stage 3 (AIDS) presents as opportunistic infections based on low CD4 count
  • Universal precautions should be used to handle body fluids: disinfect surfaces with appropriate cleaning materials (e.g., soap, cleaning rags, sponges, and mops in a one to 10 ratio bleach solution for five minutes.) And wear gloves at all times with body fluid is present.